Perrigo Company PRGO, a leading global provider of quality,
affordable healthcare products (“Perrigo”) and Elan Corporation, plc
ELN (“Elan”), a leading biotechnology company headquartered in
Ireland, today announced that, following a formal sale process conducted
by Elan, Perrigo and Elan have entered into a definitive agreement (the
“Transaction Agreement”) under which Elan will be acquired by a new
holding company incorporated in Ireland (“New Perrigo”). The cash and
stock transaction, which is valued at approximately US$8.6 billion based
on the closing price of Perrigo shares on 26 July 2013 (US$6.7 billion
excluding Elan's cash on hand), will create a global healthcare company
with an industry-leading growth profile and the geographic scale and
scope to continue building a
See full press release
Market News and Data brought to you by Benzinga APIs© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Comments
Loading...
Benzinga simplifies the market for smarter investing
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.
Join Now: Free!
Already a member?Sign in